Our website uses an automatic service to translate our content into different languages. These translations should be used as a guide only.
Good Regulatory Review Practices
Working Group Chair(s)
Food and Drug Administration (FDA)
United States of America
Melissa.Torres [at] fda.hhs.gov
The charter of the Good Regulator Review Practices (GRRP) working group is to develop guidance that establishes good regulatory review practices for regulatory authorities and/or their conformity assessment bodies.
The Review Practices (GRRP) working group aims to improve the effectiveness and efficiency of pre-market review. The GRRP working group has produced documents to support pre-market review including: